Data Last Updated: June 9, 2025

Oncotype Dx Recurrence Score - DCIS

Description

Oncotype Dx Recurrence Score-DCIS is a numeric score of a genomic test to predict the likelihood of distant recurrence of invasive breast cancer based on the assessment of 21 genes. The Oncotype DX DCIS score is a genomic test that estimates the likelihood of local recurrence (DCIS or invasive) for a patient with DCIS. The results may be used clinically to evaluate benefits of radiation therapy following surgery.

Notes

**Note 1:** **Physician statement** * Physician statement of Oncotype Dx Recurrence Score-DCIS can be used to code this data item when no other is available. **Note 2:** **Type of Test** * Record only the results of an Oncotype Dx-DCIS recurrence score in this data item. If some other test is used for scoring, assign code XX9. **Note 3:** **Multiple tests, multiple results** * In cases where Oncotype Dx-DCIS is reported on more than one in situ breast tumor specimen, record the highest value. **Note 4:** **Related data item** * Code this data item using the same report used to record the related data item 3905: Oncotype Dx Risk Level-DCIS.
Code Description
000-100 Enter actual recurrence score between 0 and 100
XX6 Not applicable, invasive case
XX7 Test ordered, results not in chart
XX8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code XX8 will result in an edit error.)
XX9 Not documented in medical record
Oncotype Dx recurrence score-DCIS not assessed or unknown if assessed